Stock BLRX BIOLINERX LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Charts BioLineRx Ltd.

Equities

BLRX

IL0011015182

Delayed TEL AVIV STOCK EXCHANGE
Other stock markets
 05:48:48 2024-07-09 am EDT 		5-day change 1st Jan Change
14.8 ILa 0.00% Intraday chart for BioLineRx Ltd. -1.33% -61.26%
May. 30 BioLineRx Ltd Announces Clinical Trial Agreement with St. Jude Children's Research Hospital, Inc. to Evaluate Motixafortide for CD34+ Hematopoietic Stem Cell Mobilization For Gene Therapy Applications in Sickle Cell Disease CI
May. 28 Transcript : BioLineRx Ltd., Q1 2024 Earnings Call, May 28, 2024

Chart: Technical Analysis

Technical analysis trends

Short TermMid-TermLong Term
Trend

Bearish

Bearish

Bearish

Resistance 16.40 24.10 29.90
Spread/Res.-9.76%-38.59%-50.50%
Spread/Supp.+10.45%+48.00%+66.48%
Support 13.40 10.00 8.890

Technical Rankings Surperformance

Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
  1. Stock Market
  2. Equities
  3. BLRX Stock
  4. Charts BioLineRx Ltd.